CN111004191A - Preparation method of large-particle-size febuxostat A crystal - Google Patents

Preparation method of large-particle-size febuxostat A crystal Download PDF

Info

Publication number
CN111004191A
CN111004191A CN201911018420.1A CN201911018420A CN111004191A CN 111004191 A CN111004191 A CN 111004191A CN 201911018420 A CN201911018420 A CN 201911018420A CN 111004191 A CN111004191 A CN 111004191A
Authority
CN
China
Prior art keywords
crystal
temperature
febuxostat
heat preservation
keeping
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201911018420.1A
Other languages
Chinese (zh)
Inventor
徐有安
袁文祥
王火箭
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wuhan Guanggu Asia-Pacific Medical Research Institute Co Ltd
Original Assignee
Wuhan Guanggu Asia-Pacific Medical Research Institute Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wuhan Guanggu Asia-Pacific Medical Research Institute Co Ltd filed Critical Wuhan Guanggu Asia-Pacific Medical Research Institute Co Ltd
Priority to CN201911018420.1A priority Critical patent/CN111004191A/en
Publication of CN111004191A publication Critical patent/CN111004191A/en
Pending legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/56Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs

Abstract

The invention provides a preparation method of large-particle-size febuxostat A crystal, which comprises the following steps: adding febuxostat into absolute ethyl alcohol, heating to 75-85 ℃ after uniformly stirring, refluxing for dissolution, filtering while the solution is hot, keeping the temperature of the filtrate at 75-85 ℃, adding water, heating the system to 75-85 ℃ after adding, keeping the temperature of the system at 75-85 ℃ after the system is dissolved, refluxing for 0.5-1.0 h, cooling to 60-63 ℃, adding febuxostat A crystal as seed crystal for induced crystallization under the condition of stirring speed of 150 plus materials at 170r/min, separating out solid from the system, keeping the temperature of the system at 60-63 ℃ for stirring crystallization for a plurality of hours, cooling the program to 35 ℃, keeping the temperature of the system at 31-35 ℃ and stirring for a certain time; the preparation method of the large-particle-size febuxostat A crystal can prepare the large-particle-size febuxostat A crystal, and the febuxostat A crystal with various particle sizes is obtained by crushing and sieving so as to be used in a preparation prescription process, so that the febuxostat tablet meeting the requirements of an original researched dissolution curve is prepared.

Description

Preparation method of large-particle-size febuxostat A crystal
Technical Field
The invention belongs to the field of febuxostat preparation, and particularly relates to a preparation method of large-particle-size febuxostat A crystal.
Background
The febuxostat mainly comprises febuxostat, and the chemical name of the febuxostat is 2- [ (3-cyano-4-isobutoxy) phenyl ] -4-methyl-5-thiazolecarboxylic acid. Is a Xanthine Oxidase (XO) inhibitor, is suitable for long-term treatment of hyperuricemia with gout symptoms, but the prior preparation method of febuxostat A crystal comprises the following steps: the invention discloses a novel febuxostat crystal form A and a preparation method (103588723B) thereof, which can only obtain febuxostat A crystals with smaller particle size (D50 ═ 16-25 mu m), but can not obtain febuxostat A crystals with various particle sizes through crushing and sieving, and have lower adaptability.
Disclosure of Invention
In order to solve the problems in the prior art, the invention provides a preparation method of large-particle-size febuxostat A crystal, and the preparation method of the large-particle-size febuxostat A crystal can be used for preparing the large-particle-size febuxostat A crystal.
In order to achieve the purpose, the invention is realized by the following technical scheme: a preparation method of large-particle-size febuxostat A crystal comprises the following steps: adding febuxostat into absolute ethyl alcohol, uniformly stirring, heating to 75-85 ℃, refluxing for dissolution, filtering while the solution is hot, keeping the temperature of the filtrate at 75-85 ℃, adding water, heating the system to 75-85 ℃ after the addition is finished, keeping the temperature of the system at 75-85 ℃, refluxing for 0.5-1.0 h, cooling to 60-63 ℃, adding febuxostat A crystals (the particle size is 20-30 microns) as seed crystals to induce crystallization under the condition of stirring speed of 150 and 170r/min, separating out solids from the system, keeping the temperature of the system at 60-63 ℃ for stirring for several hours, cooling to 35 ℃ after the program, keeping the temperature of the system at 31-35 ℃, stirring for a certain time, filtering, leaching and drying to obtain the febuxostat A crystals with large particle size (D (0.9) ═ 70 +/-10 mu m).
As a preferable mode of the invention, when the granularity of the A crystal seed is 20-30 microns (self-made), crystal transformation is not easy to occur when the temperature is kept at 60-63 ℃ for 3h and at 30-33 ℃ for 1h, and the target crystal form A can be obtained, and when the granularity of the A crystal seed is 45-56 microns, the C crystal is obtained, and the target crystal form A cannot be obtained.
As a preferred mode of the invention, the A crystal obtained by crushing can not be used as a seed crystal, otherwise, a C crystal product is obtained.
As a preferred mode of the invention, the crystal size is reduced by increasing the heat preservation temperature, the crystal size is reduced when the heat preservation time at 60-63 ℃ is too long or too short, and the crystal size is reduced, so the high-temperature heat preservation temperature is preferably 60-63 ℃ and the high-temperature heat preservation time is preferably 3 +/-0.25 h.
As a preferable mode of the invention, when the low-temperature heat preservation temperature is 15-30 ℃, the C crystal is obtained, and when the low-temperature heat preservation temperature is 30-36 ℃, the target crystal form A crystal is obtained, so the low-temperature heat preservation temperature can be 30-36 ℃, preferably 31-35 ℃, and the low-temperature heat preservation time can be 1 +/-0.25 hours.
As a preferred mode of the present invention, when the high temperature holding parameter is 60-63 ℃/3 + -0.25 hour, the low temperature holding parameter is 31-35 ℃/1 + -0.25 hour, and the temperature reduction program is selected as "0.5 hour for reducing the temperature of 62 ℃ to 56 ℃, 0.5 hour for preserving the temperature of 56 ℃, 0.5 hour for reducing the temperature of 56 ℃ to 50 ℃, 0.5 hour for preserving the temperature of 50 ℃ and 1 hour for reducing the temperature of 50 ℃ to 35", the grain size of the A crystal obtained is the largest, so the temperature reduction program is preferred.
The invention has the beneficial effects that:
1. the preparation method of the large-particle-size febuxostat A crystal can prepare the febuxostat A crystal with large particle size (D (0.9) ═ 70 +/-10 mu m) due to specific system and temperature conditions, and the febuxostat A crystal with various particle sizes is obtained by crushing and sieving so as to be used in a preparation prescription process, so that the febuxostat tablet meeting the requirements of an original grinding dissolution curve is prepared.
2. The preparation method of the large-particle-size febuxostat A crystal can be used for preparing the febuxostat A crystal with wider adaptability and is suitable for popularization.
Drawings
FIG. 1 is a flow chart of a preparation method of large-particle-size febuxostat A crystal;
FIG. 2 is a particle size distribution diagram of febuxostat A crystals in a preparation method of large-particle-size febuxostat A crystals;
FIG. 3 is an X-ray diffraction diagram of a preparation method of large-particle-size febuxostat A crystal;
Detailed Description
In order to make the technical means, the creation characteristics, the achievement purposes and the effects of the invention easy to understand, the invention is further described with the specific embodiments.
Referring to fig. 1-3, the present invention provides a technical solution: a preparation method of febuxostat A crystal with large particle size;
example 1:
adding 2.00kg of absolute ethyl alcohol into a dry and clean 5L reaction bottle at room temperature, stirring, then adding 0.50kg of febuxostat, uniformly stirring to obtain a white slurry system (the volume of the system is required to be 1/2-2/3 of the total volume of the reaction kettle), heating the system to 75-85 ℃, refluxing and dissolving, filtering while hot, keeping the temperature of the filtrate at 75-85 ℃, transferring the filtrate into a dry and clean 5L reaction bottle, stirring, adding 0.62kg of water into the filtrate, completing the addition within 0.5-1.0 hour, heating the system to 75-85 ℃ after the addition is completed, keeping the temperature of the system at 75-85 ℃, refluxing for 0.5-1.0 hour, cooling to 60-63 ℃, adding 1.5g of febuxostat A crystal (the granularity is 20-30 microns) as a crystal seed to induce crystallization under the condition that the stirring speed is 150-170r/min, separating out solid from the system, stirring and crystallizing for 3 +/-0.25 hours at the temperature of 60-63 ℃, continuously stirring and naturally cooling to 56 ℃ (the cooling rate is about 2 ℃/10min, and the temperature is reduced from 62 ℃ to 56 ℃ within about 0.5 hour), keeping the temperature and stirring for 0.5 hour, then naturally cooling to 50 ℃ (the cooling rate is about 2 ℃/10min, and the temperature is reduced from 56 ℃ to 50 ℃ within about 0.5 hour), keeping the temperature and stirring for 0.5 hour, then naturally cooling to 35 ℃ (the cooling rate is about 2.5 ℃/10min, and the temperature is reduced from 50 ℃ to 35 ℃ within about 1 hour), keeping the temperature of the system at 31-35 ℃ and stirring for 1.0 +/-0.25 hour, filtering, leaching the obtained filter cake for 1 time by using a mixed solvent of absolute ethyl alcohol and water (a mixed solvent of 180g of absolute ethyl alcohol and 20g of water), obtaining a wet product, placing the wet product into a forced air drying oven, controlling the temperature to be 55-65 ℃, and starting sampling after drying, detecting the moisture, sampling every 2 hours, inspecting, stopping drying when the detected moisture is less than or equal to 0.30%, and discharging when the temperature is reduced to less than or equal to 30 ℃. Febuxostat a crystals having a large particle size (D (0.9) ═ 73 μm) were obtained: 416g, mass yield: 83.2 percent.
Example 2:
adding 210g of absolute ethyl alcohol into a dry and clean 500mL reaction bottle at room temperature, stirring, then adding 50g of febuxostat, uniformly stirring to obtain a white slurry system (the volume of the system is required to be 1/2-2/3 of the total volume of the reaction kettle), heating the system to 80 ℃, refluxing and dissolving, filtering while hot, keeping the temperature of the filtrate at 75-85 ℃, transferring the filtrate into the dry and clean 500mL reaction bottle, stirring, adding 60g of water into the filtrate, adding after 0.5-1.0 hour, heating the system to 75-85 ℃ after the addition is finished, keeping the temperature of the system at 75-85 ℃, refluxing for 0.5-1.0 hour, cooling to 62 ℃, adding 0.15g of febuxostat A crystal (the particle size is 20-30 microns) as a seed crystal to induce crystallization under the condition that the stirring speed is controlled at 150r/min, and separating out a solid, keeping the temperature of the system at 60-63 ℃, stirring for crystallization for 3 hours, continuously stirring and naturally cooling to 50 ℃ (the cooling rate is about 2 ℃/10min, the cooling rate is about 62 ℃ to 50 ℃ within about 1 hour), keeping the temperature and stirring for 0.5 hour, then naturally cooling to 45 ℃ (the cooling rate is about 2 ℃/10min, the cooling rate is about 0.5 hour is reduced from 50 ℃ to 45 ℃), keeping the temperature and stirring for 0.5 hour, then naturally cooling to 35 ℃ (the cooling rate is about 3.3 ℃/10min, the cooling rate is about 0.5 hour is reduced from 45 ℃ to 35 ℃), keeping the temperature of the system at 31-35 ℃ and stirring for 1.0 hour, filtering, leaching the obtained filter cake with a mixed solvent of absolute ethyl alcohol and water (a mixed solvent of 90g of absolute ethyl alcohol and 2g of water) for 1 time to obtain a wet product, putting the wet product into a drying air box, controlling the temperature at 55-65 ℃, starting sampling after drying the material for 10 hours, detecting the water, sampling and sending the, when the water content is detected to be less than or equal to 0.30 percent, stopping drying when the water content is qualified, cooling to be less than or equal to 30 ℃, discharging to obtain febuxostat A crystals with large grain diameter (D (0.9) ═ 72 mu m): 40.6g, mass yield: 81.2 percent.
Example 3:
adding 2.10kg of absolute ethyl alcohol into a dry and clean 5L reaction bottle at room temperature, stirring, then adding 0.50kg of febuxostat, uniformly stirring to obtain a white slurry system (the volume of the system is required to be 1/2-2/3 of the total volume of the reaction kettle), heating the system to 75-85 ℃, refluxing and dissolving, filtering while hot, keeping the temperature of the filtrate at 75-85 ℃, transferring the filtrate into a dry and clean 5L reaction bottle, stirring, adding 0.52kg of water into the filtrate, finishing adding after 0.5-1.0 hour, heating the system to 75-85 ℃ after finishing adding, keeping the temperature of the system at 75-85 ℃, refluxing for 0.5-1.0 hour, cooling to 62 ℃, adding 1.5g of febuxostat A crystal (the particle size is 20-30 micrometers) as seed crystal for inducing crystallization under the condition that the stirring speed is controlled at 160r/min, separating out solid from the system, keeping the temperature of the system at 60-63 ℃, stirring and crystallizing for 3 hours, continuously stirring and naturally cooling to 50 ℃ (the cooling rate is about 2 ℃/10min, and the cooling rate is about 1 hour from 62 ℃ to 50 ℃), stirring for 0.5 hr under heat preservation, naturally cooling to 35 deg.C (cooling rate of about 1.7 deg.C/10 min, cooling from 50 deg.C to 35 deg.C for about 1.5 hr), maintaining the system temperature at 31-35 deg.C, stirring for 1 hr, filtering, leaching the obtained filter cake with mixed solvent of anhydrous ethanol and water (mixed solvent of 180g anhydrous ethanol and 20g water) for 1 time to obtain wet product, placing the wet product into a forced air drying oven, controlling the temperature at 55-65 ℃, starting sampling after drying the material for 14h, detecting the moisture, then sampling and inspecting every 2 h, when the detected moisture is less than or equal to 0.30%, stopping drying when the product is qualified, cooling to less than or equal to 30 ℃, discharging to obtain febuxostat A crystal with large particle size (D (0.9) ═ 69 mu m): 414g, mass yield: 82.8 percent.
Example 4:
adding 200g of absolute ethyl alcohol into a dry and clean 500mL reaction bottle at room temperature, stirring, then adding 50g of febuxostat, uniformly stirring to obtain a white slurry system (the volume of the system is required to be 1/2-2/3 of the total volume of the reaction kettle), heating the system to 80 ℃, refluxing and dissolving, filtering while hot, keeping the temperature of the filtrate at 75-85 ℃, transferring the filtrate into the dry and clean 500mL reaction bottle, stirring, adding 70g of water into the filtrate, adding after 0.5-1.0 hour, heating the system to 75-85 ℃ after the addition is finished, keeping the temperature of the system at 75-85 ℃, refluxing for 0.5-1.0 hour, cooling to 62 ℃, adding 0.15g of febuxostat A crystal (the particle size is 20-30 microns) as a seed crystal to induce crystallization under the condition that the stirring speed is 170r/min, and separating out a solid from the system, keeping the temperature of the system at 60-63 ℃ for stirring and crystallizing for 3 hours, continuously stirring and naturally cooling to 35 ℃ (the cooling rate is about 1.5 ℃/10min, and the temperature is reduced from 62 ℃ to 35 ℃ for about 3 hours), then keeping the temperature of the system at 31-35 ℃ for stirring for 1.0 hour, filtering, leaching the obtained filter cake for 1 time by using a mixed solvent of absolute ethyl alcohol and water (a mixed solvent of 90g of absolute ethyl alcohol and 2g of water) to obtain a wet product, putting the wet product into a blast drying oven, controlling the temperature at 55-65 ℃, starting sampling after drying for 10 hours, detecting the moisture, sampling and inspecting every 2 hours, stopping drying when the detected moisture is less than or equal to 0.30%, cooling to less than or equal to 30 ℃, discharging to obtain the febuxostat A crystal with a large particle size (D (0.9) ═ 63.5 mu m): 42.2g, mass yield: 84.3 percent.
1 ] seed crystal investigation:
【1】 Influence of seed crystal size on crystal form:
Figure BDA0002246428020000061
【2】 Influence of the particle size of the A seed crystals obtained by crushing on the crystal form:
Figure BDA0002246428020000062
2, investigation of high-temperature heat preservation temperature and high-temperature heat preservation time:
Figure BDA0002246428020000063
Figure BDA0002246428020000071
3, investigation of low-temperature heat preservation temperature and low-temperature heat preservation time:
Figure BDA0002246428020000072
4' examination of the influence of the cooling procedure on the crystal particle size:
Figure BDA0002246428020000073
Figure BDA0002246428020000081
while there have been shown and described what are at present considered the fundamental principles and essential features of the invention and its advantages, it will be apparent to those skilled in the art that the invention is not limited to the details of the foregoing exemplary embodiments, but is capable of other specific forms without departing from the spirit or essential characteristics thereof. The present embodiments are therefore to be considered in all respects as illustrative and not restrictive, the scope of the invention being indicated by the appended claims rather than by the foregoing description, and all changes which come within the meaning and range of equivalency of the claims are therefore intended to be embraced therein. Any reference sign in a claim should not be construed as limiting the claim concerned.
Furthermore, it should be understood that although the present description refers to embodiments, not every embodiment may contain only a single embodiment, and such description is for clarity only, and those skilled in the art should integrate the description, and the embodiments may be combined as appropriate to form other embodiments understood by those skilled in the art.

Claims (6)

1. A preparation method of febuxostat A crystal with large particle size is characterized by comprising the following steps: adding febuxostat into absolute ethyl alcohol, uniformly stirring, heating to 75-85 ℃, refluxing for dissolution, filtering while the solution is hot, keeping the temperature of the filtrate at 75-85 ℃, adding water, heating the system to 75-85 ℃ after the addition is finished, keeping the temperature of the system at 75-85 ℃, refluxing for 0.5-1.0 h, cooling to 60-63 ℃, adding febuxostat A crystals (the particle size is 20-30 microns) as seed crystals to induce crystallization under the condition of stirring speed of 150 and 170r/min, separating out solids from the system, keeping the temperature of the system at 60-63 ℃ for stirring for several hours, cooling to 35 ℃ after the program, keeping the temperature of the system at 31-35 ℃, stirring for a certain time, filtering, leaching and drying to obtain the febuxostat A crystals with large particle size (D (0.9) ═ 70 +/-10 mu m).
2. The method for preparing febuxostat A crystal with large particle size according to claim 1, which is characterized in that: when the granularity of the A crystal seeds is 20-30 microns (self-made), crystal transformation is not easy to occur when the temperature is kept for 3 hours at 60-63 ℃ and is kept for 1 hour at 30-33 ℃, and the target crystal form A can be obtained, and when the granularity of the A crystal seeds is 45-56 microns, the C crystal is obtained, and the target crystal form A cannot be obtained.
3. The method for preparing febuxostat A crystal with large particle size according to claim 1, which is characterized in that: the A crystal obtained by crushing can not be used as a seed crystal, otherwise, a C crystal product is obtained.
4. The method for preparing febuxostat A crystal with large particle size according to claim 1, which is characterized in that: the granularity of the crystal obtained by increasing the heat preservation temperature is reduced, the heat preservation time at 60-63 ℃ is too long or too short, and the granularity of the obtained crystal is reduced, so the high-temperature heat preservation temperature is preferably 60-63 ℃, and the high-temperature heat preservation time is preferably 3 +/-0.25 h.
5. The method for preparing febuxostat A crystal with large particle size according to claim 1, which is characterized in that: when the low-temperature heat preservation temperature is 15-30 ℃, the C crystal is obtained, and when the low-temperature heat preservation temperature is 30-36 ℃, the target crystal form A crystal is obtained, so that the low-temperature heat preservation temperature can be 30-36 ℃, preferably 31-35 ℃, and the low-temperature heat preservation time can be 1 +/-0.25 hours.
6. The method for preparing febuxostat A crystal with large particle size according to claim 1, which is characterized in that: when the high-temperature heat preservation parameter is 60-63 ℃/3 +/-0.25 hours, the low-temperature heat preservation parameter is 31-35 ℃/1 +/-0.25 hours, and the temperature reduction program selects '0.5 hour when the temperature is reduced to 56 ℃, 0.5 hour when the temperature is reduced to 50 ℃, 0.5 hour when the temperature is maintained to 50 ℃ and 1 hour when the temperature is reduced to 35'), the grain size of the obtained A is the largest, so the temperature reduction program is preferably selected.
CN201911018420.1A 2019-10-24 2019-10-24 Preparation method of large-particle-size febuxostat A crystal Pending CN111004191A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201911018420.1A CN111004191A (en) 2019-10-24 2019-10-24 Preparation method of large-particle-size febuxostat A crystal

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201911018420.1A CN111004191A (en) 2019-10-24 2019-10-24 Preparation method of large-particle-size febuxostat A crystal

Publications (1)

Publication Number Publication Date
CN111004191A true CN111004191A (en) 2020-04-14

Family

ID=70110858

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201911018420.1A Pending CN111004191A (en) 2019-10-24 2019-10-24 Preparation method of large-particle-size febuxostat A crystal

Country Status (1)

Country Link
CN (1) CN111004191A (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1275126A (en) * 1998-06-19 2000-11-29 帝人株式会社 Polymorphic modifications of 2-(3-cyano-4-isobutyloxyphenyl)-4-methyl-5-thiazole-carboxylic acid and processes for the preparation thereof
JP2011020950A (en) * 2009-07-15 2011-02-03 Mitsutaka Kitamura Method for producing crystal polymorph of 2-(3-cyano-4-isobutyloxyphenyl)-4-methylthiazole-5-carboxylic acid
WO2011141933A2 (en) * 2010-05-12 2011-11-17 Msn Laboratories Limited Process for preparation of 2-[3-cyano-4-(2-methylpropoxy)phenyl]-4-methylthiazole-5-carboxylic acid and its pharmaceutically acceptable salts
CN103588724A (en) * 2013-09-10 2014-02-19 杭州华东医药集团生物工程研究所有限公司 Febuxostat crystal form A and preparation method thereof
CN106565627A (en) * 2016-10-10 2017-04-19 扬子江药业集团有限公司 Preparation method for pharmaceutical crystal form of febuxostat

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1275126A (en) * 1998-06-19 2000-11-29 帝人株式会社 Polymorphic modifications of 2-(3-cyano-4-isobutyloxyphenyl)-4-methyl-5-thiazole-carboxylic acid and processes for the preparation thereof
JP2011020950A (en) * 2009-07-15 2011-02-03 Mitsutaka Kitamura Method for producing crystal polymorph of 2-(3-cyano-4-isobutyloxyphenyl)-4-methylthiazole-5-carboxylic acid
WO2011141933A2 (en) * 2010-05-12 2011-11-17 Msn Laboratories Limited Process for preparation of 2-[3-cyano-4-(2-methylpropoxy)phenyl]-4-methylthiazole-5-carboxylic acid and its pharmaceutically acceptable salts
CN103588724A (en) * 2013-09-10 2014-02-19 杭州华东医药集团生物工程研究所有限公司 Febuxostat crystal form A and preparation method thereof
CN106565627A (en) * 2016-10-10 2017-04-19 扬子江药业集团有限公司 Preparation method for pharmaceutical crystal form of febuxostat

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
李远: "非布司他及A晶合成工艺研究", 《中国优秀硕士学位论文全文数据库 工程科技I辑》 *

Similar Documents

Publication Publication Date Title
CN111138502B (en) Crystallization process of large-particle sucralose
WO2022117074A1 (en) Method for preparing crystalline d-psicose
CN102329212A (en) Refining method for long-chain binary acid
CN105274625B (en) A kind of high crystalline density spheroidization NTO crystal and preparation method
CN111004191A (en) Preparation method of large-particle-size febuxostat A crystal
CN110759366B (en) Preparation method of magnesium sulfate
CN113620794A (en) Crystallization method for preparing large-particle-size ethyl vanillin
CN108997238A (en) A kind of preparation method of fine grained NTO
CN102894247A (en) Technology for producing greasy crystallized honey
CN207445656U (en) A kind of device that a large amount of crystallite kinds are prepared using wet-milling of simplification
CN107188798A (en) A kind of process for refining of sodium citrate of controllable granularity and realize device
CN110527854A (en) Method for preparing particle size controllable ultra-pure ammonium rhenate crystal
CN111454255B (en) Preparation method of small-particle-size azilsartan
CN105418524A (en) Method for preparing special 3-nitro-1,2,4-triazole-5-ketone
CN110526879B (en) Crystallization preparation method of small-granularity febuxostat
CN104817557B (en) A kind of stable crystal form of moxifloxacin hydrochloride and preparation method thereof
CN110606817B (en) Refining method of brivaracetam
CN106580888A (en) Isotretinoin A acid particle preparation method
CN110818816B (en) Refining and crystallizing method of sugammadex sodium
CN113105439A (en) Method for preparing small-particle-size olmesartan medoxomil crystals
JP5966186B2 (en) Method for producing calcite single crystal
CN111848388A (en) Crystals of dodecanedioic acid and preparation method thereof
CN112552199B (en) Preparation method of large-crystal high-bulk-density mefenamic acid
CN102212016A (en) Preparation method of acrylamide crystal with ultra low water content
EA036793B1 (en) Crystallization process for obtaining canagliflozin hemihydrate crystals

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20200414